Fundraising Fox

Cure Pharmaceutical Holding

Oxnard, US · Founded 2014 · Delaware corporation

Biotech

Founders & leadership

CB
CHARLES BERMANNamed on SEC filing
EM
EDWARD MALISKINamed on SEC filing
MU
MARK UDELLNamed on SEC filing
WY
WILLIAM YUANNamed on SEC filing
RD
ROBERT DAVIDSONNamed on SEC filing
AE
ALAN EINSTEINNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$31.5M disclosed across 3 rounds · 2018–2020

▶$11.5MraisedNov 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DavidsonExecutive Officer, Director
  • John BellDirector
  • Lauren ChungDirector
  • Anya GoldinDirector
  • Josh HeldDirector
  • Ruben King-ShawDirector
  • Gene SalkindDirector
  • William YuanDirector
  • Nancy DuitchDirector
  • Mike RedardExecutive Officer
Offering amount
$11.5M
Amount sold
$11.5M
Finders' fees
$306K
Placement agents
Axiom Capital Management, Inc.
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19MraisedMay 2019 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DavidsonExecutive Officer, Director
  • Alex KatzExecutive Officer
  • Mark UdellExecutive Officer
  • Alan EinsteinDirector
  • William YuanDirector
  • Charles BermanDirector
  • Jessica RoussetExecutive Officer
Offering amount
$19M
Amount sold
$19M
First sale
May 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedApr 2018 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • CHARLES BERMANDirector
  • EDWARD MALISKIExecutive Officer
  • MARK UDELLExecutive Officer
  • WILLIAM YUANDirector
  • ROBERT DAVIDSONDirector
  • ALAN EINSTEINDirector
Offering amount
$5M
Amount sold
$1M
Minimum investment
$10K
Sales commissions
$100K
Placement agents
Alexander Capital, L.P.
First sale
Mar 2018
Incorporated
Corporation, Nevada, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cure Pharmaceutical Holding raised?
Cure Pharmaceutical Holding has disclosed $31.5M raised across 3 rounds.
Where is Cure Pharmaceutical Holding headquartered?
Cure Pharmaceutical Holding is headquartered in Oxnard, US.